Diabetes Clinical Trials in Miami

Showing 221-240 of 388 trials

Multiple Dose Study Of PF-04937319 In Patients With Type 2 Diabetes

NCT01272804

The purpose of this study is to characterize the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of PF-04937319 following multiple (14 days) escalating oral doses in patients with type 2 diabetes.

Diabetes Mellitus, Type 2NIDDM

Pfizer61 participantsStarted Feb 2011

Miami, Florida, United States • South Miami, Florida, United States • South Miami, Florida, United States +1 more locations

COMPLETEDPhase 3< 1 mile

A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine

NCT00976391

This study will examine the safety and efficacy of albiglutide in combination with insulin glargine as compared with the combination of insulin glargine and preprandial lispro insulin in subjects with type 2 diabetes.

Diabetes Mellitus, Type 2

GlaxoSmithKline586 participantsStarted Sep 2009

Birmingham, Alabama, United States • Dothan, Alabama, United States • Gilbert, Arizona, United States +206 more locations

Multiple Dose Study Of PF-04937319 In Patients With Type 2 Diabetes

A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine

Diabetes Trials in Other Cities

Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes

A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 Diabetes

Comparison of NN5401 Versus Insulin Glargine, Both Combined With Metformin Treatment, in Subjects With Type 2 Diabetes

A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease

A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin

A Phase IIA Study of BMS-512148 to Assess Safety, Exposure, and Biological Effects in Stable Type 2 Diabetic Subjects

A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes

In-patient Study With GSK716155 In Patients With Type 2 Diabetes Mellitus

Safety and Efficacy of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart as Mealtime Insulin in Type 1 Diabetes

A Study of Aleglitazar in Patients With Type 2 Diabetes

A Trial Comparing Sequential Addition of Insulin Aspart Versus Further Dose Increase With Insulin Degludec/Liraglutide in Subjects With Type 2 Diabetes Mellitus, Previously Treated With Insulin Degludec/Liraglutide and Metformin and in Need of Further Intensification

A Study to Evaluate Cardiovascular Outcomes in Patients With Type 2 Diabetes Treated With ITCA 650

CANagliflozin Treatment And Trial Analysis-Sulfonylurea (CANTATA-SU) SGLT2 Add-on to Metformin Versus Glimepiride

A Titration Study of a Glucagon-Like Peptide-1 (GLP-1) Analogue in Patients With Type 2 Diabetes Treated With Metformin.

A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

GLP-1 Receptor Agonist Lixisenatide (Morning or Evening) in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin

A Drug-Drug Interaction Study of GK Activator (2) and Glyburide in Patients With Type 2 Diabetes.

Observational Study on the Effect of NovoMix® 30, Levemir® or NovoRapid® (Alone or Combined) in Type 2 Diabetics Previously Treated With Anti-diabetic Medication

Other Conditions in Miami